YangLi Ph.D. (Alex)


(T) + 1.202.879.3654

Dr. Alex Li advises clients around the world on a wide range of matters that involve complex scientific and technical issues. His practice includes both emerging companies and multinational corporations in the chemical, pharmaceutical, biotechnology, semiconductor, and software sectors.

Alex's experience includes patent prosecution, freedom-to-operate analysis, software licensing, IP due diligence, IP agreements, cross-border IP transactions, and Hatch-Waxman litigations.

In assisting clients, Alex draws on his significant technical knowledge and research experience from his graduate studies in chemistry. He has authored a number of peer-reviewed scientific publications on subjects such as asymmetric catalysis, computational molecular modeling, and quantum dots. Prior to joining Jones Day, Alex worked as a patent agent for several law firms in the Washington, D.C. area.


  • Zeavion Holding Pte. Ltd. contract assumed in Gymboree bankruptcyJones Day successfully represented Zeavion Holding Pte. Ltd., a significant trademark license holder, in connection with, among other things, the assumption and assignment of a significant trademark license and ancillary agreement from Gymboree to The Children's Place in connection with Gymboree's section 363 sale of substantially all of certain Gymboree assets to The Children's Place.
  • Celgene to be acquired by Bristol-Myers Squibb for approx. $74 billionJones Day advised Celgene Corporation (NASDAQ: CELG) in connection with the intellectual property and technology transactions aspects of its cash-and-stock merger with Bristol-Myers Squibb (NYSE: BMY) which has an equity value of approximately $74 billion.
  • We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.